These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24943970)

  • 1. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
    Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
    Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
    Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic effects of heme oxygenase-1 inhibitor on Kasumi-1 cells via the ATF4/CHOP/Ire-1α pathway.
    Wei SX; Wang YT; Chai QX; Fang Q; Zhang YM; Wang JS
    Genet Mol Res; 2015 Jun; 14(2):5994-6002. PubMed ID: 26125799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
    Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways.
    Do MT; Kim HG; Khanal T; Choi JH; Kim DH; Jeong TC; Jeong HG
    Toxicol Appl Pharmacol; 2013 Sep; 271(2):229-38. PubMed ID: 23707609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of metformin on growth inhibition and oestradiol production in breast cancer cells.
    Rice S; Pellat L; Ahmetaga A; Bano G; Mason HD; Whitehead SA
    Int J Mol Med; 2015 Apr; 35(4):1088-94. PubMed ID: 25716282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells' Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines.
    Banisharif Dehkordi F; Ghatrehsamani M; Abdolvand M; Soltani A; Masoumi SH
    Curr Pharm Des; 2024; 30(17):1341-1353. PubMed ID: 38676476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production.
    Mdkhana B; Zaher DM; Abdin SM; Omar HA
    Phytomedicine; 2021 Mar; 83():153470. PubMed ID: 33524703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
    Cai H; Everett RS; Thakker DR
    Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
    Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
    Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
    Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
    PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.